Edwards Pays Boston Scientific $180M, Ending All IP Fights
Edwards Lifesciences Corp. has agreed to pay Boston Scientific Corp. $180 million to settle all patent litigation worldwide tied to coronary repair devices, the companies announced Tuesday....To view the full article, register now.
Already a subscriber? Click here to view full article